ep passion crn - mdepinet.orgmdepinet.org/wp-content/uploads/ep-passion-crn.pdf · 2019-12-18 ·...

1
Electrophysiology Predictable and Sustainable Implementation of National Registries: EP PASSION Li Wang, PhD, MBA, MS, Daniel Canos, PhD, MPH, Hetal Patel, MS, Jessica Paulsen, BS, Kimberly Selzman, MD, Benjamin Eloff, PhD, Danica Marinac-Dabic, MD, PhD, MMSc, FISPE. Office of Surveillance and Biometrics & Office of Device Evaluation, Center for Devices and Radiological Health U.S. Food and Drug Administration, Silver Spring, MD. 20903 The Regulatory Gap Traditional Post-Approval Inefficiencies Stand-Alone Study Pace and Enrollment Difficulty Prolonged Completion Time Next Generation on market before “Lessons Learned” Traditional Post-Market Study Cost ~$10 million in traditional PAS studies Potential 40-60% savings with registry based surveillance EP PASSION Objectives EP PASSION is focused on implantable cardioverter defibrillator system leads and pulse generators and cardiac resynchronization therapy left heart leads. A RWE- based approach can streamline post-approval studies by: Reducing Cost Reduce time to enrollment completion Reduce loss to follow-up Provide timely answers to post-market questions Objective 1: Transition long-term direction patient follow-up assessment in current post- approval studies (PAS) towards a real world evidence approach (RWE). Objective 2: Develop sustainable mechanism to collect long-term chronic performance of new and substantially modified pacing and defibrillation leads. EP PASSION Components Phase II: ID Phase III: Develop New/Modify Phase IV: Develop Linked Approach EP PASSION Phased Approach EP PASSION Post-Approval Study Transition Extant Registry/EHR Claims Remote Monitoring Implant & Periprocedural Data Annual Follow-Up Annual Follow-Up Traditional PAS Transition of Ongoing PAS ~10 Years <10 Years Novel RWE PAS <10 Years EP PASSION Influence The shift towards RWE in the EP field has already begun…. FDA recently approved the Boston Scientific S-ICD Post-Approval Study with no pre-market data. The powered, hypothesis-driven study incorporates the ACC NCDR registry, Boston Scientific’s LATITUDE NXT Patient Management System, CMS/Truven claims, and the National Death Index. EP PASSION Partners EP PASSION Timeline

Upload: others

Post on 11-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: EP PASSION CRN - MDEpiNet.orgmdepinet.org/wp-content/uploads/EP-PASSION-CRN.pdf · 2019-12-18 · EP PASSION Phased Approach EP PASSION Post-Approval Study Transition Extant Registry/EHR

Electrophysiology Predictable and Sustainable Implementation of National Registries: EP PASSION

LiWang,PhD,MBA,MS,DanielCanos,PhD,MPH,HetalPatel,MS,JessicaPaulsen,BS,KimberlySelzman,MD,BenjaminEloff,PhD,Danica Marinac-Dabic, MD,PhD,MMSc,FISPE.

OfficeofSurveillance and Biometrics &Office ofDevice Evaluation,CenterforDevices and RadiologicalHealthU.S.Foodand Drug Administration, SilverSpring,MD.20903

TheRegulatoryGapTraditionalPost-ApprovalInefficiencies• Stand-AloneStudy• PaceandEnrollmentDifficulty• ProlongedCompletionTime• NextGenerationonmarketbefore“LessonsLearned”TraditionalPost-MarketStudyCost• ~$10millionintraditionalPASstudies

• Potential40-60%savingswithregistrybasedsurveillance

EPPASSIONObjectivesEPPASSIONisfocusedonimplantablecardioverterdefibrillatorsystemleadsandpulsegeneratorsandcardiacresynchronizationtherapyleftheartleads.ARWE-basedapproachcanstreamlinepost-approvalstudiesby:

• ReducingCost• Reducetimetoenrollmentcompletion• Reducelosstofollow-up• Providetimelyanswerstopost-marketquestions

Objective1:• Transitionlong-termdirectionpatientfollow-upassessmentincurrentpost-

approvalstudies(PAS)towardsarealworldevidenceapproach(RWE).Objective2:• Developsustainablemechanismtocollectlong-termchronicperformanceof

newandsubstantiallymodifiedpacinganddefibrillationleads.

EPPASSIONComponents

Phase II: ID & Assess

Phase III: Develop New/Modify

Phase IV: Develop Linked Approach

EPPASSIONPhasedApproachEPPASSIONPost-ApprovalStudyTransition

ExtantRegistry/EHR

Claims RemoteMonitoring

Implant&Periprocedural

DataAnnual

Follow-Up

AnnualFollow-Up

TraditionalPAS

TransitionofOngoingPAS

~10Years

<10Years

NovelRWEPAS<10Years

EPPASSIONInfluenceTheshifttowardsRWEintheEPfieldhasalreadybegun….• FDArecentlyapprovedtheBostonScientificS-ICDPost-ApprovalStudy

withnopre-marketdata.Thepowered,hypothesis-drivenstudyincorporatestheACCNCDRregistry,BostonScientific’sLATITUDENXTPatientManagementSystem,CMS/Truven claims,andtheNationalDeathIndex.

EPPASSIONPartners

EPPASSIONTimeline